For clinicians
Staying curious about what's really going on.
The questions we ask, the way we listen, and the care that follows.
The case you already know
A young person who should be getting better, and isn't.
Every clinician has this patient. Good formulation, reasonable plan, real effort on everyone's part — and the needle does not move. The language available to describe it is unkind and unhelpful: resistant, non-adherent, complex.
Our experience is that it is almost always a picture problem. Something structural was never seen, because nothing in the pathway was designed to look for it. That is not a failure of clinical skill. It is a failure of the order in which we were taught to work.
What we do differently
We spend the time at the start.
A fuller assessment before a plan is committed to, deliberately wider than the presenting complaint: development, attention, learning, language, sleep, sensory experience, and the family and school world the young person is actually living in.
It costs more at the front. It costs dramatically less over the following two years, because far fewer plans have to be abandoned and restarted — and because the young person spends less of their adolescence being treated for the wrong thing.
What it looks like in practice
Three habits, not a protocol.
Ask what has already been tried
Including what failed, and how it felt to the young person when it did. A history of things not working is the most under-read part of most notes.
Treat understanding as an outcome
What a young person comes to know about themselves is not a by-product of the work. It is durable after discharge in a way that symptom relief alone is not, so we measure it.
Say the formulation out loud
To the young person, in their words, and to the people around them. A formulation nobody has heard cannot be corrected — and being understood is itself part of the treatment.
What it changes
When we understand more, young people need less.
87%+
of young people with anxiety, depression or ADHD find real, measurable relief.
1.8×
the response to the first ADHD treatment we try, against around half under usual care.
50%
less reliance on stimulant medication than the national average (39% against 81%).
85%
fewer crisis level hospital admissions, among the best outcomes payers measure.
From Navera's founding US practice. Before and after assessments, 2025 to 2026, with 2,672 young people. US research, with Europe to follow.
Working together
We are looking for colleagues, not converts.
We are building this in Sweden with clinicians who already know their population, their pathways and their pressures far better than we do. What we bring is a method and the infrastructure to hold it steady; what we need is people willing to test it honestly against the young people in front of them, and to tell us where it does not fit.
If that sounds like a conversation worth having, we would like to hear from you.